https://www.marketscreener.com/quote/stock/CULLINAN-THERAPEUTICS-INC-117317644/news/Cullinan-Oncology-Inc-Announces-First-Clinical-Data-from-its-Phase-1-Study-of-CLN-619-in-Patients-43970295/?utm_source=telegram&utm_medium=social&utm_campaign=share